abc biopply
Allschwil, Switzerland biopply.com
From their website, Nov 2026
Work here? Claim this listing
About
abc biopply AG provides preclinical CRO services and assay licensing based on proprietary 3D CoSeedis humanized multi-organoid in-chip technology. It works with biotech and pharma clients on drug efficacy, safety, toxicity, resistance, biomarker development, and custom disease-model design from its sites in Allschwil, Basel and Solothurn, Switzerland.
Services
Preclinical CRO Services
Validated preclinical services for drug efficacy, safety, toxicity, resistance, and biomarker development on clinically relevant multi-organoid disease models.
Service Packages
Bundled assay sets for drug development questions such as efficacy, resistance, toxicity, safety, target validation, marker studies, omics, and study planning.
Assays
Highly standardized and validated 3D CoSeedis in-chip assays for individual preclinical readouts and project-specific study needs.
Licenses
In-licensing options for the company's assays, protocols, disease models, and technology for in-house use.
Custom-tailored model development
Design and development of custom disease models, including characterization and biomarker discovery.
Integrated preclinical services
Preclinical services that combine in vitro to in vivo work synchronized with humanized mouse models through partner laboratories.
Target validation package
Package for target localization, binding, activation, tissue penetration, and cytotoxicity studies during drug development and optimization.
Rapid Drug Efficacy Check
Package for rapid prediction of clinically relevant drug efficacy and dosage using 3D CoSeedis tumor models and dose-response readouts.
Drug Safety Package
Package covering IC50 determinations and off-target toxicity studies.
Drug Resistance Check
Package covering IC50 determinations and long-term efficacy studies.
Personalized Efficacy Package
Package for efficacy testing on PDCs with IC50 and dose-response studies.
Personalized Toxicity Target and off-Target Package
Package for IC50, dose-response, and off-target toxicity studies on PDCs.
Pathway Analysis Package
Package for IC50 determination and pathway dissection studies.
Drug Response Package
Package for IC50 determination, dose-response, and clonal response studies.
Cell Viability Package
Package for IC50 determination, dose-response, and cell survival studies.
Organoid service packages
Bundles validated assay modules for drug efficacy, resistance, relapse, toxicity, safety, marker studies, tissue penetration, and omics.
Licensing of assays and protocols
Provides in-licensing options for proprietary assays, protocols, disease models, and technology for in-house use.
Custom disease model development
Designs and custom-tailors disease models and supports biomarker discovery for client projects.
Integrated preclinical study support
Supports preclinical study design and planning and connects in vitro work with humanized mouse models through partners.
- Turnaround
- 10 weeks to result · 12 weeks to result
- What to send
- Choose a 3D CoSeedis tumor model · One drug - one target
Capabilities
- Assays and studies
- Toxicology · In vivo · Rodent models · Apoptosis · Co-culture · Cytotoxicity · Dose response · Drug efficacy · Tumor relapse · Histology · Live cell detection · Antibody penetration
11 more
Late stage cancer relapse · Colony forming · Off-target cytotoxicity · Drug penetration · Marker studies · Omics · IC50 determination · Drug efficacy assay · Drug safety assay · Toxicology assay · Drug resistance assay - Scale and capacity
- Up to 1000 replicates
- Therapeutic areas
- Oncology · Neurology · Hepatology · Nephrology · Obesity · Cartilage · Renal
Instruments and platforms
- 3D CoSeedis in chip technology
- 3D CoSeedis™ chips
Modalities and species
- Modalities
- Organoid models · Multi-organoid disease models · Humanized mouse models · Patient-derived cells · Organoid · Humanized multi-organoid disease models
- Species and models
- 3D CoSeedis tumor models · Oncology · Neurology · Hepatic · Renal · Cartilage · Obesity · PDCs · Humanized mouse models · Patient tissues · Healthy tissues · Diseased tissues
Industries served
- Biotech
- Pharma
Company
- Type
- CRO
- Founded
- 2018
Locations
- Address
- Hegenheimermattweg 167A, 4123 Allschwil, Switzerland
- Sites
- Allschwil, Basel, Switzerland · Solothurn, Switzerland
- Serves
- Switzerland, EU, Canada, international, CH
Similar labs
Work here? Claim this listing